About
Angstrom AI builds GenAI-based molecular simulations to substitute wet lab experiments in the pre-clinical drug development pipeline. We are a team of 2 PhD's and 2 Professors from the University of Cambridge who decided to start a company together after we realised how to combine breakthoughs in our research in quantum-accurate models of physics and generative AI models. Our Biotech/Pharma clients can verify the efficacy and safety of new drug candidates using our computer simulations, which. Ångström AI was founded by Jose Miguel Hernandez Lobato and Laurence Midgley. Headquarters: San Francisco, United States.
- Headquarters
- San Francisco, United States
- Founders
- Jose Miguel Hernandez Lobato and Laurence Midgley
- Verified backers
- Not disclosed
- Industry
- AI
Trade on Ångström AI
Ångström AI shares
No active listings yet.
Be the first to post →FAQ
Ångström AI private shares
Practical questions on buying, selling, and pricing Ångström AI stock in the secondary market.
How to buy Ångström AI shares?
Ångström AI is privately held, so there is no public ticker and no exchange order book. Stock typically changes hands when early investors, employees, or funds with existing positions decide to sell, often via a broker or a structured secondary. Transfers are usually subject to the company’s right of first refusal and other restrictions in the stockholders’ agreement. If you are eligible, you can post a buy request on Bubex so holders looking to exit Ångström AI can find you.
What is Ångström AI share price?
There is no official Ångström AI share price. Private names do not print a close. Indicative levels can be inferred from the last priced round, tender offers, and reported secondaries, but those prints are not executable quotes and they often disagree with one another. Cross-check platforms and brokers; the better execution is usually the one you actually get filled at, not the headline mark.
Are Ångström AI shares publicly traded?
No. Ångström AI is not listed on NYSE, Nasdaq, or any other public exchange. Any purchase is an off-exchange transfer of existing private stock (or an interest in a vehicle that holds it), not an IPO subscription.
When is the Ångström AI IPO?
Nobody knows. Ångström AI has not filed to go public, and private companies do not publish an IPO date in advance. Rumours, banker mandates, and “late 20XX” chatter are not a timetable — many names stay private, get acquired, or slip the listing by years. Until a registration statement is actually filed, treat any IPO date as unknown and use the secondary market if you need access before a listing.
Who can buy Ångström AI shares on the secondary market?
Secondary access to Ångström AI is generally limited to accredited investors and other eligible counterparties. Even then, the company or its transfer agent may need to approve the transferee. Bubex introduces buyers and sellers; it is not a broker-dealer and does not execute, custody, or settle the trade.
Can I sell Ångström AI shares?
Existing holders — typically employees after a vesting event, early investors, or funds — may be able to sell, subject to lock-ups, ROFR, and company policy. If you hold Ångström AI stock and want liquidity, you can post a sell offer on Bubex to find qualified buyers rather than waiting for a company-run tender.
How is Ångström AI valued if it is still private?
Private-market value is not a single number. Practitioners look at the last primary round, any 409A, reported tender prices, and implied marks from secondaries. Those inputs can diverge: secondaries often trade at a discount or, less often, a premium to the last round. Bubex surfaces the latest disclosed round and any market indications we can corroborate; treat them as context, not a valuation opinion.
What is the difference between Ångström AI’s last funding round and a secondary trade?
A funding round is a primary issuance: the company sells new shares and the post-money valuation is reset. A secondary trade is a transfer of shares already outstanding between two holders; it does not recapitalise Ångström AI the same way. Secondary price per share can therefore sit well away from the last-round mark, which is why you should not treat the headline valuation as your entry price.
Information and introductions only. Bubex does not provide investment advice, brokerage, execution, custody, or settlement. Secondary transfers remain subject to company consents and applicable securities law.